- Upexi Inc (NASDAQ:UPXI) has entered into definitive agreements with institutional and accredited investors for the purchase and sale of 2.1 million shares at $3.30 per share.
- The offer price represents a 24% discount to the closing price as of May 11.
- The shares are being sold under a registered direct offering for gross proceeds of approximately $7 million.
- The closing of the offering is expected to occur on or about May 16, 2023.
- Also Read: Upexi’s Tytan Tiles Toy Brand Inks Licensing Agreement With Walt Disney
- Price Action: UPXI shares are trading lower by 16.8% at $3.60 on the last check Friday.
Aytu BioPharma Announces Continuing Availability Of ADHD Medication Adzenys XR-ODT(R) In Response To Reported Generic Adderall(R) XR Supply Disruptions
Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, with a development pipeline addressing rare, pediatric-onset
